Mostrando 7 resultados de: 7
Filtros aplicados
Publisher
Scientific Reports(3)
Emerging Infectious Diseases(1)
Journal of Infection(1)
Toxins(1)
Wellcome Open Research(1)
Área temáticas
Microorganismos, hongos y algas(7)
Enfermedades(4)
Farmacología y terapéutica(1)
Fisiología y materias afines(1)
Genética y evolución(1)
Origen
scopus(7)
Animal derived antibodies should be considered alongside convalescent human plasma to deliver treatments for COVID-19
OtherAbstract: Published data on the first 5,000 coronavirus patients to receive plasma shows promise in the UnitedPalabras claves:Antibodies, covid19, hyper-immune sera, Plasma, therapyAutores:Ainsworth S., Pleass R.J., Stefanie K. MenziesFuentes:scopusExploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms
ArticleAbstract: Snakebite is a neglected tropical disease that causes high rates of global mortality and morbidity.Palabras claves:antivenom, immunogen, neglected tropical diseases, polyclonal antibodies, recombinant expression, serine proteases, snake venom toxin, snakebiteAutores:Ainsworth S., Alomran N., Alsolaiss J., Blundell P., Casewell N.R., Crittenden E., Dawson C.A., Edge R.J., Hall S.R., Harrison R.A., Stefanie K. Menzies, Wilkinson M.C.Fuentes:scopusIgg seroconversion and pathophysiology in severe acute respiratory syndrome coronavirus 2 infection
ArticleAbstract: We investigated the dynamics of seroconversion in severe acute respiratory syndrome coronavirus 2 (SPalabras claves:Autores:Adams E.R., Augustin Y., Byrne R.L., Clark D.J., Cocozza M., Cubas-Atienzar A.I., Cuevas L.E., Cusinato M., Davies B.M.O., Davis M., Davis P., Duvoix A., Eckersley N.M., Fitchett J.R.A., Forton D., Fraser A.J., Garrod G., Hadcocks L., Hu Q., Johnson M., Kay G.A., Kirwan D.E., Klekotko K., Krishna S., Lewis Z., Macallan D.C., Mensah-Kane J., Monahan I., Moore C.M., Nebe-Von-Caron G., Owen S.I., Planche T., Sainter C., Sall A.A., Schouten J., Staines H.M., Stefanie K. Menzies, Wilkins J., Williams C.T., Woolston K.Fuentes:scopusTwelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies
ArticleAbstract: Background: There are an abundance of commercially available lateral flow assays (LFAs) that detectPalabras claves:covid-19, IGG, Igm, Lateral flow immunoassays, SARS-COV-2Autores:Adams E.R., Baldwin L., Brown L., Byrne R.L., Collins A.M., Cubas-Atienzar A.I., Cuevas L.E., de Vos M., Edwards T., Escadafal C., Ferreira D.M., Fletcher T.E., Fraser A.J., Garrod G., Hyder-Wright A., Kay G.A., Kontogianni K., Mason J., Mitsi E., Owen S.I., Planche T., Sacks J.A., Stefanie K. Menzies, Taylor J., Todd S., Tully C., Williams C.T.Fuentes:scopusSelf-sampling of capillary blood for SARS-CoV-2 serology
ArticleAbstract: Serological testing is emerging as a powerful tool to progress our understanding of COVID-19 exposurPalabras claves:Autores:Adams E.R., Brown L., Byrne R.L., Cubas-Atienzar A.I., Cuevas L.E., Fitchett J.R.A., Fletcher T.E., Fraser A.J., Garrod G., Kay G.A., Kontogianni K., Krishna S., Owen S.I., Planche T., Sainter C., Staines H.M., Stefanie K. Menzies, Turtle L., Williams C.T.Fuentes:scopusVirus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognition
ArticleAbstract: Antivenom is currently the first-choice treatment for snakebite envenoming. However, only a low propPalabras claves:Autores:Ainsworth S., Alsolaiss J., Casewell N.R., Crittenden E., Dawson C.A., Edge R.J., Hall S.R., Harrison R.A., Stefanie K. Menzies, Wilkinson M.C.Fuentes:scopusSARS-CoV-2 enzyme-linked immunosorbent assays as proxies for plaque reduction neutralisation tests
ArticleAbstract: Severe acute respiratory coronavirus 2 (SARS-CoV-2) has spread globally since its emergence in 2019.Palabras claves:Autores:Adams E.R., Clark D.J., Cuevas L.E., Davies B.M.O., Eckersley N.M., Giorgi E., Hughes G.L., Kay G.A., Kirwan D.E., Krishna S., Owen S.I., Patterson E.I., Planche T., Staines H.M., Stefanie K. Menzies, Williams C.T.Fuentes:scopus